About the Alliance
The Bill & Melinda Gates Foundation, Biotechnology Industry Organization (BIO), Global Health Progress (GHP), International AIDS Vaccine Initiative (IAVI), Infectious Disease Research Institute (IDRI), Association of University Technology Managers (AUTM) and World Health Organization's Special Programme for Research and Training in Tropical Diseases (TDR), have joined together to prepare a set of multi-sector case studies to identify ways in which key stakeholders are addressing global health concerns.
The Alliance invites organizations and individuals who are currently involved in the global health community to download and share these case studies widely so that we may further our collective goals.
About the Organizations
Association of University Technology Managers (AUTM): AUTM is a global network of more than 3,500 technology transfer professionals who work in academic, research, government, legal and commercial settings. AUTM is dedicated to promoting and supporting technology transfer through education, advocacy, networking and communication.
Biotechnology Industry Organization (BIO): BIO is the world’s largest biotechnology organization, a non-profit headquartered in Washington, D.C. BIO provides advocacy, business development, and communications services worldwide for its 1,100+ member organizations—both large and small—who are involved in the research and development of innovative health care, agricultural, industrial and environmental biotechnology products.
The Bill & Melinda Gates Foundation: Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people’s health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life.
Global Health Progress: The Global Health Progress initiative brings together research-based biopharmaceutical companies and global health leaders to improve health in the developing world. The initiative provides a platform for research-based biopharmaceutical companies, governments, public health leaders, universities, foundations, and other stakeholders to share experiences and best practices and to forge new partnerships.
Infectious Disease Research Institute (IDRI): IDRI is a Seattle, Washington-based not-for-profit committed to applying innovative science to the research and development of products to prevent, detect and treat infectious diseases of poverty. By integrating capabilities, IDRI strives to create an efficient pathway to bring scientific innovation from the lab to the people who need it most.
International AIDS Vaccine Initiative (IAVI): IAVI is an international not-for-profit organization whose mission is to ensure the development of safe, effective, accessible prophylactic AIDS vaccines for use throughout the world. IAVI is headquartered in the United States, with regional offices in Amsterdam, Delhi, Nairobi and Johannesburg, and operates in 25 countries. IAVI works in partnership with governments, civil society, academic institutions and industry in its research and development, advocacy and policy activities.
Special Programme for Research and Training in Tropical Diseases (TDR): TDR is an independent global program of scientific collaboration that helps coordinate, support and influence global efforts to combat a portfolio of major diseases of the poor and disadvantaged. TDR is administered by the World Health Organization, and co-sponsored by the United Nations Children’s Fund, the United Nations Development Programme, the World Bank and the World Health Organization.
Others involved in this project include:
Pam Baker (1st edition only)
Ashley Mastandrea (1st edition only)
John Otrompke, J.D. (1st edition only)
David Perilstein (1st edition only)
Jill Hronek, The Sherwood Group, Inc., firstname.lastname@example.org
Shirley Soda Opasinski, The Sherwood Group, Inc.
Pam Reid, The Sherwood Group, Inc.